You are here

Breathonix targets HSA approval for Covid-19 test in Q1 2021, US$20 price point

SINGAPORE-BASED startup Breathonix is targeting to receive provisional authorisation from the Health Sciences Authority (HSA) for its 60-second Covid-19 breath test by Q1 2021.

Breathonix is targeting a service model, with a price point of US$20 per test, said Kok Beng Neo, chairman of...

BT is now on Telegram!

For daily updates on weekdays and specially selected content for the weekend. Subscribe to t.me/BizTimes